HC Wainwright reiterated their buy rating on shares of Protara Therapeutics ( NASDAQ:TARA – Free Report ) in a research report sent to investors on Friday morning, Benzinga reports. They currently have a $23.00 target price on the stock. Protara Therapeutics Price Performance Shares of TARA traded down $0.12 during mid-day trading on Friday, hitting $2.42. The stock had a trading volume of 44,496 shares, compared to its average volume of 37,030. The firm has a market cap of $27.37 million, a P/E ratio of -0.

https://www.dailypolitical.com/2023/08/05/protara-therapeutics-nasdaqtara-given-buy-rating-at-hc-wainwright.html

#dailypolitical